Moleculin Biotech is trading 11.57% higher at $0.58, mainly as biotech gains and recovery buying follow the prior selloff.
- Shares fell 32.71% to $0.52 on September 21, 2026.
- No new company-specific announcement was identified on September 22; the latest official release concerns September 14 conference presentations.
- Biotech is up 2.07%, and the rebound is not supported by a fresh company catalyst.